Comparative cardiac haemodynamics of bisoprolol, celiprolol, carvedilol and nebivolol in normal volunteers.
Nebivolol is a novel selective beta 1-adrenergic antagonist with an unusual haemodynamic profile. It improves left ventricular function in normals and in patients with a damaged left ventricle. We compared the cardiac effects of a 14-day treatment period with 10 mg o.d. of bisoprolol, 400 mg o.d. of celiprolol, 25 mg o.d. of carvedilol and 5 mg o.d. of nebivolol in a placebo-controlled crossover study in 7 volunteers with a mean age of 39 (range 30-53) years. Cardiac haemodynamics were assessed serially by means of systolic time intervals. The ratio of the preejection period to the left ventricular ejection time (PEP/LVET) was used as a indirect measure of left ventricular performance. The results show that the PEP/LVET is a very sensitive and reproducible index of left ventricular function. During treatment with placebo and bisoprolol no changes occurred; during treatment with celiprolol and carvedilol a significant but transient decrease of PEP/LVET occurred, and only during treatment with nebivolol a long-lasting and significant decrease of PEP/LVET occurred. With bisoprolol an increase of PEP and QS2c (total electromechanical systole) was observed, indicative of a negative inotropic effect. In conclusion, nebivolol, in contrast with both classical and vasodilating beta-blocking agents, substantially improves left ventricular function, possibly due to an improvement of diastolic function and left ventricular compliance, which may be of therapeutical value in the treatment of congestive heart failure.
Clinical Research Unit, St. Bartholomeus, Jan Palijn G.H., Merksem, Belgium.
J
J
De Cree
L
L
Van Nueten
H
H
Geukens
H
H
Verhaegen
D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001578:Benzopyrans / Q000494:pharmacology*; D017298:Bisoprolol / Q000494:pharmacology; D002227:Carbazoles / Q000494:pharmacology; D000077261:Carvedilol; D017272:Celiprolol / Q000494:pharmacology; D004562:Electrocardiography; D004983:Ethanolamines / Q000494:pharmacology*; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009200:Myocardial Contraction / Q000187:drug effects; D000068577:Nebivolol; D011412:Propanolamines / Q000494:pharmacology; D016277:Ventricular Function, Left / Q000187:drug effects
D000319:Adrenergic beta-Antagonists; D001578:Benzopyrans; D002227:Carbazoles; D004983:Ethanolamines; D011412:Propanolamines; D000068577:Nebivolol; D000077261:Carvedilol; D017272:Celiprolol; D017298:Bisoprolol